Is plasma atherogenic index or LDL/HDL ratio more predictive of peripheral arterial disease complexity?

Ali Evsen1, Adem Aktan2, Mehmet Altunova3

  • 1Department of Cardiology, Dağkapı State Hospital, Diyarbakır, Turkey.

Vascular
|June 11, 2024
PubMed

Insights

The LDL/HDL ratio is a more valuable predictor of peripheral arterial disease (PAD) complexity than the atherogenic plasma index (AIP). This study found LDL/HDL ratio to be an independent predictor of PAD complexity.

Area of Science:

  • Cardiovascular Medicine
  • Medical Diagnostics
  • Lipid Metabolism

Background:

  • Peripheral arterial disease (PAD) is primarily caused by atherosclerosis.
  • Dyslipidemia is a key contributor to atherosclerosis development.
  • Novel lipid ratios may offer predictive value for PAD complexity.

Purpose of the Study:

  • To evaluate the predictive capability of specific dyslipidemia ratios, Atherogenic Plasma Index (AIP) and LDL/HDL ratio, for peripheral arterial disease (PAD) complexity.
  • To compare the efficacy of AIP and LDL/HDL ratio in predicting PAD complexity.

Main Methods:

  • Retrospective analysis of 305 PAD patients.
  • Classification of PAD complexity using TASC-II criteria based on angiography.
  • Determination of Atherogenic Plasma Index (AIP) using Log (TG/HDL) and LDL/HDL ratio.
  • Logistic regression analysis to identify independent predictors of PAD complexity.

Main Results:

  • Higher prevalence of diabetes mellitus and coronary artery disease in the complex PAD group (TASC C-D).
  • Patients with complex PAD exhibited significantly higher triglycerides, LDL-C, AIP, and LDL/HDL ratio, and lower HDL-C.
  • Multivariate analysis identified diabetes mellitus, coronary artery disease, and LDL/HDL ratio as independent predictors of PAD complexity.

Conclusions:

  • The LDL/HDL ratio is a more valuable and independent predictor of peripheral arterial disease (PAD) complexity compared to the Atherogenic Plasma Index (AIP).
  • This finding highlights the clinical utility of the LDL/HDL ratio in assessing PAD severity.